186 related articles for article (PubMed ID: 25938926)
1. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2015 May; 31(4):187-8. PubMed ID: 25938926
[No Abstract] [Full Text] [Related]
2. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017; 33(6):423-425. PubMed ID: 28618236
[No Abstract] [Full Text] [Related]
3. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2020 Apr; 36(3):135-136. PubMed ID: 32074465
[No Abstract] [Full Text] [Related]
4. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2015 Feb; 31(1):1. PubMed ID: 25562125
[No Abstract] [Full Text] [Related]
5. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2021 Dec; 37(10):543-544. PubMed ID: 34882496
[No Abstract] [Full Text] [Related]
6. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013 Jun; 29(5):449. PubMed ID: 23725200
[No Abstract] [Full Text] [Related]
7. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2015 Jun; 31(5):257. PubMed ID: 26039112
[No Abstract] [Full Text] [Related]
8. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013 May; 29(4):379. PubMed ID: 23627907
[No Abstract] [Full Text] [Related]
9. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013; 29(6):513-4. PubMed ID: 23841863
[No Abstract] [Full Text] [Related]
10. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2014 Aug; 30(6):445-6. PubMed ID: 24978906
[No Abstract] [Full Text] [Related]
11. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013 Sep; 29(7):611. PubMed ID: 23981251
[No Abstract] [Full Text] [Related]
12. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2015 Mar; 31(2):61-2. PubMed ID: 25715098
[No Abstract] [Full Text] [Related]
13. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2015 Oct; 31(8):445-6. PubMed ID: 26367793
[No Abstract] [Full Text] [Related]
14. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2020 May; 36(4):199-200. PubMed ID: 32186947
[No Abstract] [Full Text] [Related]
15. Patent watch: Have the biosimilar floodgates been opened in the United States?
Brinckerhoff CC; Schorr K
Nat Rev Drug Discov; 2015 May; 14(5):303-4. PubMed ID: 25924576
[No Abstract] [Full Text] [Related]
16. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2014 Dec; 30(10):799. PubMed ID: 25474692
[No Abstract] [Full Text] [Related]
17. Assessing biosimilarity and interchangeability of biosimilar products.
Chow SC
Stat Med; 2013 Feb; 32(3):361-3. PubMed ID: 23307569
[No Abstract] [Full Text] [Related]
18. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2020 Jun; 36(5):267-268. PubMed ID: 32320310
[No Abstract] [Full Text] [Related]
19. Considerations in the early development of biosimilar products.
Li EC; Abbas R; Jacobs IA; Yin D
Drug Discov Today; 2015 May; 20 Suppl 2():1-9. PubMed ID: 25572407
[TBL] [Abstract][Full Text] [Related]
20. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2018 Sep; 34(7):487-488. PubMed ID: 30095353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
